# Lipoprotein(a) in Japanese Patients With Cardiovascular Disease: A Systematic Review

## TL;DR

This paper reviews the link between high Lp(a) levels and cardiovascular disease in Japanese patients, highlighting the need for standardized definitions and further research.

## Contribution

The paper provides a systematic review of Lp(a)'s role in cardiovascular disease specifically within the Japanese population.

## Key findings

- Elevated Lp(a) levels are consistently associated with increased cardiovascular risk in Japanese patients.
- Variability in study design and definitions of 'high' Lp(a) complicates comparisons across studies.
- No approved therapies target elevated Lp(a), but ongoing trials may provide future treatment options.

## Abstract

Lipoprotein(a) [Lp(a)] is recognized as an independent risk factor for cardiovascular disease (CVD), but its characterization within the Japanese population remains unexplored. This systematic literature review synthesizes evidence on the association between Lp(a) levels and CVD in Japanese patients. To ensure comparability, the review focused on studies using the widely used LATEX-based immunoassay method. Most studies categorized patients into “high” and “low” Lp(a) groups; this review concentrates on findings from the “high” groups to evaluate the impact of elevated Lp(a). Although definitions of “high” Lp(a) varied, a consistent association between elevated Lp(a) and increased cardiovascular risk has been observed, aligning with international findings. Variability across studies was noted, likely due to differences in study design, endpoints, and follow-up durations. Although no approved therapies specifically target elevated Lp(a), several randomized controlled trials are currently ongoing. Continued research is essential to better understand the clinical implications of elevated Lp(a) among Japanese individuals.

•Lp(a) is a known CV risk factor, but its clinical relevance in Japan is understudied.•Elevated Lp(a) levels are associated with increased CV risk; standardized definitions remain critical.•Future research should establish consensus definitions and CVD management strategies for elevated Lp(a) in Japan.

Lp(a) is a known CV risk factor, but its clinical relevance in Japan is understudied.

Elevated Lp(a) levels are associated with increased CV risk; standardized definitions remain critical.

Future research should establish consensus definitions and CVD management strategies for elevated Lp(a) in Japan.